• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人成纤维细胞和转染人尿激酶受体的小鼠成纤维细胞中,趋化性和促有丝分裂性尿激酶受体相互作用后第二信使的产生。

Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.

作者信息

Anichini E, Fibbi G, Pucci M, Caldini R, Chevanne M, Del Rosso M

机构信息

Institute of General Pathology, Florence University, Italy.

出版信息

Exp Cell Res. 1994 Aug;213(2):438-48. doi: 10.1006/excr.1994.1221.

DOI:10.1006/excr.1994.1221
PMID:8050501
Abstract

We studied urokinase-type plasminogen activator (u-PA)-dependent chemotaxis and DNA synthesis in both human fibroblasts and LB6 mouse fibroblasts transfected with human u-PA receptor (u-PAR) gene (LB6 clone 19). Both cell lines have receptors for the amino-terminal fragment of u-PA (u-PA-ATF). We observed that u-PA and u-PA-ATF stimulated chemotactic migration of both LB6 clone 19 cells and human fibroblasts, which could be impaired by down-regulation of protein kinase C (PKC) with phorbol myristate acetate (PMA). While LB6 clone 19 cells were unable to undergo mitosis following exposure to either u-PA or u-PA-ATF, human fibroblasts were stimulated to mitosis by exogenous addition of native u-PA, and u-PA-ATF was ineffective. The mitogenic activity of u-PA on human fibroblasts could also be impaired by down-regulation of PKC with PMA. We studied second messenger formation following u-PAR stimulation. Neither inositol lipid metabolism nor intracellular Ca2+ content were affected, while an increase of diacylglycerol (DAG) generation was observed. Such DAG formation was related to de novo synthesis from glucose and was dependent on ligand-receptor interaction. Both u-PA-ATF and the native u-PA molecule were able to stimulate DAG formation, u-PA being from three to fourfold more efficient than ATF. These data suggest that u-PAR stimulation per se is sufficient to trigger DAG formation. The native molecule confers on the cell an additional stimulus, possibly related with the activation of a u-PA-catalytic site-dependent substrate. Such stimulation allows the cell to reach the DAG threshold level required to trigger DNA synthesis.

摘要

我们研究了尿激酶型纤溶酶原激活剂(u-PA)依赖性趋化作用以及转染了人u-PA受体(u-PAR)基因的人成纤维细胞和LB6小鼠成纤维细胞(LB6克隆19)中的DNA合成。这两种细胞系都有u-PA氨基末端片段(u-PA-ATF)的受体。我们观察到u-PA和u-PA-ATF刺激了LB6克隆19细胞和人成纤维细胞的趋化迁移,用佛波醇肉豆蔻酸酯乙酸酯(PMA)下调蛋白激酶C(PKC)可损害这种迁移。虽然LB6克隆19细胞在暴露于u-PA或u-PA-ATF后无法进行有丝分裂,但外源性添加天然u-PA可刺激人成纤维细胞进行有丝分裂,而u-PA-ATF无效。用PMA下调PKC也会损害u-PA对人成纤维细胞的促有丝分裂活性。我们研究了u-PAR刺激后的第二信使形成。肌醇脂质代谢和细胞内Ca2+含量均未受影响,而观察到二酰甘油(DAG)生成增加。这种DAG形成与葡萄糖的从头合成有关,并且依赖于配体-受体相互作用。u-PA-ATF和天然u-PA分子都能够刺激DAG形成,u-PA的效率比ATF高3至4倍。这些数据表明,u-PAR刺激本身足以触发DAG形成。天然分子赋予细胞额外的刺激,可能与u-PA催化位点依赖性底物的激活有关。这种刺激使细胞能够达到触发DNA合成所需的DAG阈值水平。

相似文献

1
Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.人成纤维细胞和转染人尿激酶受体的小鼠成纤维细胞中,趋化性和促有丝分裂性尿激酶受体相互作用后第二信使的产生。
Exp Cell Res. 1994 Aug;213(2):438-48. doi: 10.1006/excr.1994.1221.
2
Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.尿激酶型纤溶酶原激活剂与其受体的相互作用迅速诱导葡萄糖转运蛋白的激活。
Biochemistry. 1997 Mar 18;36(11):3076-83. doi: 10.1021/bi9619379.
3
Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.针对尿激酶受体的反义寡核苷酸可阻断体外尿激酶依赖性血管生成及二酰基甘油的产生。
Lab Invest. 1998 Sep;78(9):1109-19.
4
Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.纤溶酶介导的潜在转化生长因子-β向转化生长因子-β细胞转化过程中受体结合型尿激酶的需求。
J Cell Physiol. 1994 Mar;158(3):398-407. doi: 10.1002/jcp.1041580303.
5
Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.尿激酶-尿激酶受体相互作用:人表皮细胞中的非促有丝分裂信号转导
Biochem Biophys Res Commun. 1993 Jan 29;190(2):347-52. doi: 10.1006/bbrc.1993.1054.
6
Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.乙醇诱导培养的人内皮细胞中尿激酶受体上调。
Alcohol Clin Exp Res. 2001 Feb;25(2):163-70.
7
Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.人单链尿激酶与中国仓鼠卵巢细胞的结合及仓鼠尿激酶型纤溶酶原激活物受体的克隆
Thromb Haemost. 1998 Jul;80(1):148-54.
8
The urokinase receptor and cell migration.尿激酶受体与细胞迁移
Semin Thromb Hemost. 1996;22(6):513-6. doi: 10.1055/s-2007-999053.
9
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.尿激酶型纤溶酶原激活剂、其受体及1型尿激酶型纤溶酶原激活剂抑制剂对卡波西肉瘤和毛细血管内皮细胞体外生长及侵袭的影响:HIV-Tat蛋白的作用
Int J Oncol. 2005 Jul;27(1):223-35.
10
Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.透明质酸抑制骨关节炎和类风湿关节炎患者滑膜成纤维细胞中尿激酶型纤溶酶原激活物(u-PA)、纤溶酶原激活物抑制剂-1(PAI-1)和尿激酶型纤溶酶原激活物受体(u-PAR)的表达。
J Rheumatol. 2000 Apr;27(4):997-1004.

引用本文的文献

1
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.雷洛昔芬可降低类风湿关节炎患者滑膜细胞中尿激酶型纤溶酶原激活物依赖性增殖。
Arthritis Res Ther. 2005;7(6):R1244-53. doi: 10.1186/ar1815. Epub 2005 Sep 8.
2
Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.尿激酶及其受体在体外基础状态和刺激状态下结肠上皮细胞迁移中的作用。
Gut. 2000 Jul;47(1):105-11. doi: 10.1136/gut.47.1.105.
3
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.
尿激酶型纤溶酶原激活剂通过不同的受体依赖性和蛋白水解依赖性机制诱导人平滑肌细胞迁移和增殖。
Mol Cell Biochem. 1999 May;195(1-2):199-206. doi: 10.1023/a:1006936623106.
4
Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist.
Clin Exp Metastasis. 1998 Jan;16(1):9-20. doi: 10.1023/a:1006503816792.
5
Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.尿激酶型纤溶酶原激活剂在小鼠血管创伤愈合过程中对细胞周围纤溶酶和基质金属蛋白酶蛋白水解的非受体依赖性作用
J Cell Biol. 1998 Jan 12;140(1):233-45. doi: 10.1083/jcb.140.1.233.
6
Generation and characterization of urokinase receptor-deficient mice.尿激酶受体缺陷小鼠的产生与特性研究
J Clin Invest. 1996 Feb 1;97(3):870-8. doi: 10.1172/JCI118489.